In 2023, Dr. Jaume Pons earned $1.79M in total compensation at ALX Oncology Holdings Inc., including $649.74K salary, $357.36K bonus and $779.00K in stock. Most recently sold 2,652 shares in Feb 2025. Currently holds stock worth $822.73K. Led ALX Oncology Holdings Inc. as CEO for 2 years.
Compensation History
Annual executive compensation data for Dr. Jaume Pons, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.79M
Salary
$649.74K
Bonus
$357.36K
Other
$0.00
Salary
$649.74KBoard Justification
The compensation philosophy is designed to attract, engage, and retain executive officers while aligning their interests with those of stockholders through performance-based incentives.
Bonus
$357.36KBoard Justification
The annual target bonus for Dr. Pons was set at 55% of his annual base salary, based on the achievement of corporate goals for 2023.
Other Compensation
$0.00Board Justification
No additional compensation was reported for Dr. Pons in 2023.
Restricted Stock
Board Justification
The value of stock awards that vested in 2023, calculated based on the fair value at the time of vesting.
Performance Metrics
The performance metrics for Dr. Pons' compensation were based on corporate goals related to specific programs, trials, and corporate progress.
Dr. Jaume Pons
Ex-CEO of ALX Oncology Holdings Inc.
Sector of Economy
Healthcare
CEO of ALX Oncology Holdings Inc. for
2 years 8 months (Dec 2020 - Sep 2023)
Previous Experience
President and Chief Executive Officer of ALX Oncology Holdings Inc.
Other ALX Oncology Holdings Inc. CEOs
Holdings
Track Dr. Jaume Pons's stock holdings and portfolio value over time.
Total Stock Sold
$10.83M
$10.83M
320,062 ALXO shares
What if they kept their stock?
If Dr. Jaume Pons didn't sell their stock, today they would have:
Extra ALXO320,062 shares worth $454.49K.
This is -95.8% and $10.38M less than what they got when they sold the stock.
Insider Trading
Dr. Jaume Pons's recent stock transactions, purchases, and sales filed with the SEC.
$3.05K
ALXO at $1.15/share
Feb 19, 2025
Sale
$17.06K
ALXO at $1.58/share
Dec 30, 2024
Sale
$5.00K
ALXO at $2.58/share
Aug 14, 2024
Sale
$158.08K
ALXO at $7.90/share
Jul 11, 2024
Sale
$62.60K
ALXO at $5.82/share
Jul 1, 2024
Sale
$168.65K
ALXO at $8.43/share
Jun 4, 2024
Sale
$318.33K
ALXO at $15.92/share
May 6, 2024
Sale
$710.20K
ALXO at $14.20/share
Apr 16, 2024
Sale
$223.04K
ALXO at $11.15/share
Apr 4, 2024
Sale
30,000 shares
ALXO
Feb 14, 2024
Received
Rivals
Compare Dr. Jaume Pons with competitor CEOs and industry peers.